Arcadia Biosciences (RKDA)

Nasdaq Market Open

Arcadia Biosciences, Inc. is a consumer-focused food and agricultural products company with roots in crop science and trait development. The company has shifted from a primarily agricultural biotechnology profile toward branded consumer goods, while retaining selected intellectual property and product opportunities connected to agronomic traits. Its current reported revenue base is led by Zola coconut water, a packaged beverage brand sold into the US consumer market.

Arcadia’s portfolio spans food, beverage, body care and agricultural applications. Zola Coconut Water gives the company exposure to the better-for-you beverage category, where brands compete on taste, distribution, retail shelf space and consumer interest in hydration and natural ingredients. The company’s agricultural history includes work on wheat traits and other plant-science applications designed to improve crop performance or end-market value, although its commercial focus has narrowed compared with earlier stages of the business.

The company reports one operating segment and generates most of its revenue in the United States. It also has geographic links to markets including Argentina, India and Canada, reflecting the international nature of agricultural research, trait licensing and crop commercialization. Arcadia’s scale is small compared with major food, beverage and agricultural input companies, so its results can be sensitive to brand traction, distribution agreements, working capital needs and portfolio changes.

For investors, Arcadia Biosciences represents a niche small-cap company combining consumer packaged goods with a legacy in agricultural innovation. Its distinctive feature is the blend of branded products such as Zola and science-based assets tied to crop development, rather than a pure-play beverage, personal care or seed technology model.

0.92 USD
−0.01 (-0.99%)

Last updated

Market Cap
2.08M
P/E
P/FCF
P/S
0.44
Enterprise Value
1.12M
Sector
Energy
Industry
Crude Petroleum and Natural Gas
Address
5956 SHERRY LANE, DALLAS, TX
GlobeNewswire Inc.

Arcadia acquires ENGIE Impact to create best-in-class energy management platform

01 May 2026, 15:00 PM
GlobeNewswire Inc.

Cority Continues to Be a Leader in the Sustainability Software Market, According to Prominent Industry Analyst Report

16 Jul 2025, 12:00 PM
GlobeNewswire Inc.

$TOCKHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger – EVGR, QTRX, RKDA, EBTC

15 Feb 2025, 01:30 AM
GlobeNewswire Inc.

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CCRN, RKDA, ENLC on Behalf of Shareholders

06 Dec 2024, 19:53 PM
GlobeNewswire Inc.

Population Health Management Market to Attain $663.75 Bn by 2034

28 Nov 2024, 05:30 AM
Investing.com

Arcadia Biosciences Announces Executive Changes - Investing.com

08 Jul 2024, 22:17 PM
Zacks Investment Research

Arcadia Biosciences (RKDA) Sells GoodWheat Brand to Above Food

17 May 2024, 18:28 PM
Zacks Investment Research

Arcadia Biosciences (RKDA) Shares Gain on Q1 Earnings Beat

16 May 2024, 18:12 PM
Zacks Investment Research

Arcadia Biosciences (RKDA) Reports Q1 Loss, Tops Revenue Estimates

10 May 2024, 00:20 AM
Zacks Investment Research

Arcadia Biosciences (RKDA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

02 May 2024, 16:01 PM
Zacks Investment Research

New Strong Sell Stocks for April 22nd

22 Apr 2024, 12:43 PM
Zacks Investment Research

Arcadia Biosciences (RKDA) Q4 Earnings Beat Mark, Sales Up Y/Y

01 Apr 2024, 17:21 PM
Zacks Investment Research

Arcadia Biosciences (RKDA) Reports Q4 Loss, Misses Revenue Estimates

29 Mar 2024, 01:25 AM
Zacks Investment Research

Zacks Industry Outlook Highlights like West Fraser Timber, CalMaine Foods, GrowGeneration, Hydrofarm and Arcadia Biosciences

16 Feb 2024, 15:54 PM
Zacks Investment Research

5 Agriculture - Products Stocks to Watch in a Challenging Industry

15 Feb 2024, 17:58 PM
Zacks Investment Research

Zacks Industry Outlook Highlights Bunge, The Andersons and Arcadia Biosciences

28 Nov 2023, 10:50 AM
Zacks Investment Research

3 Agriculture - Products Stocks to Watch in a Promising Industry

27 Nov 2023, 18:07 PM
Zacks Investment Research

GrowGeneration (GRWG) Reports Q3 Loss, Tops Revenue Estimates

09 Nov 2023, 00:25 AM
Zacks Investment Research

New Strong Buy Stocks for October 25th

25 Oct 2023, 12:51 PM
Zacks Investment Research

New Strong Buy Stocks for October 17th

17 Oct 2023, 12:40 PM
Market Cap
2.08M
Enterprise Value
1.12M
P/E
P/B
0.72
P/S
0.44
EV / EBITDA
-0.3
EV / Sales
0.24
EPS
-4.53
Dividend Yield
0%
P/FCF
P/CF
Free Cash Flow
ROE
-323.15%
ROA
-175.15%
Debt / Equity
0
Current Ratio
3.79
Quick Ratio
3.17
Cash
0.7
Avg Volume
2.11M
Fundamentals Snapshot Price
1.01

Income Statement

Line Item 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1
Revenue 1.1M 901K 1.3M 1.46M 1.2M
Gross profit 400K 192K 418K 631K 518K
Operating income -779K -1.38M -1.15M -501K 530K
EBITDA -771K -1.37M -1.15M -486K 543K
Net income -4.39M -1.34M 856K -4.46M 2.6M
Basic EPS -2.11 -0.98 0.63 -3.26 1.9
Diluted EPS -2.11 -0.98 0.62 -3.26 1.9

Balance Sheet

Line Item 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1
Total assets 5.32M 6.55M 8.58M 7.79M 12.99M
Total liabilities 2.44M 2.41M 3.14M 3.26M 4.09M
Total equity 2.89M 4.14M 5.44M 4.53M 8.91M
Cash & equivalents 954K 259K 1.12M 1.38M 3.16M
Current assets 5.17M 6.36M 8.39M 7.58M 8.85M
Current liabilities 1.37M 2.06M 2.29M 1.84M 2.22M

Cash Flow

Line Item 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1
Operating cash flow -1.1M -861K -257K -2.03M -1.59M
Investing cash flow 0 0 250K 500K
Financing cash flow 1.79M 0 1K 0 5K
Change in cash 695K -861K -256K -1.78M -1.08M
Kind Filing Date Link
edgar index SCHEDULE 13G — Arcadia Biosciences, Inc. View Filing
edgar index 8-K — Arcadia Biosciences, Inc. View Filing
edgar index 10-Q — Arcadia Biosciences, Inc. View Filing
eight k text 8-K — 8-K View Filing
edgar index 8-K — Arcadia Biosciences, Inc. View Filing
eight k text 8-K — 8-K View Filing
edgar index 8-K — Arcadia Biosciences, Inc. View Filing
edgar index 10-K — Arcadia Biosciences, Inc. View Filing
eight k text 8-K — 8-K View Filing
ten k section 10-K — business View Filing
ten k section 10-K — mda View Filing
ten k section 10-K — risk_factors View Filing
edgar index 424B3 — Arcadia Biosciences, Inc. View Filing
edgar index EFFECT — Arcadia Biosciences, Inc. View Filing
edgar index 8-K — Arcadia Biosciences, Inc. View Filing
eight k text 8-K — 8-K View Filing
edgar index UPLOAD — Arcadia Biosciences, Inc. View Filing
edgar index CORRESP — Arcadia Biosciences, Inc. View Filing
edgar index S-3 — Arcadia Biosciences, Inc. View Filing
edgar index CORRESP — Arcadia Biosciences, Inc. View Filing
edgar index D — Arcadia Biosciences, Inc. View Filing
edgar index RW — Arcadia Biosciences, Inc. View Filing
edgar index 8-K — Arcadia Biosciences, Inc. View Filing
eight k text 8-K — 8-K View Filing
edgar index 8-K — Arcadia Biosciences, Inc. View Filing
edgar index 425 — Arcadia Biosciences, Inc. View Filing
eight k text 8-K — 8-K View Filing
edgar index 8-K — Arcadia Biosciences, Inc. View Filing
eight k text 8-K — 8-K View Filing
edgar index DEF 14A — Arcadia Biosciences, Inc. View Filing
edgar index ARS — Arcadia Biosciences, Inc. View Filing
edgar index 8-K — Arcadia Biosciences, Inc. View Filing
edgar index 10-Q — Arcadia Biosciences, Inc. View Filing
eight k text 8-K — 8-K View Filing
edgar index 8-K — Arcadia Biosciences, Inc. View Filing
eight k text 8-K — 8-K View Filing
edgar index 8-K — Arcadia Biosciences, Inc. View Filing
eight k text 8-K — 8-K View Filing
edgar index SCHEDULE 13G — Arcadia Biosciences, Inc. View Filing
edgar index 8-K — Arcadia Biosciences, Inc. View Filing
edgar index 425 — Arcadia Biosciences, Inc. View Filing
edgar index 10-Q — Arcadia Biosciences, Inc. View Filing
edgar index S-4/A — Arcadia Biosciences, Inc. View Filing
edgar index 8-K — Arcadia Biosciences, Inc. View Filing
edgar index 4 — Arcadia Biosciences, Inc. View Filing
edgar index 4 — Arcadia Biosciences, Inc. View Filing
form 4 Form 4 — Schaefer Thomas J. View Filing
form 4 Form 4 — Kawakami Mark View Filing
edgar index 8-K — Arcadia Biosciences, Inc. View Filing
edgar index 425 — Arcadia Biosciences, Inc. View Filing
edgar index 10-Q — Arcadia Biosciences, Inc. View Filing
edgar index 8-K — Arcadia Biosciences, Inc. View Filing
edgar index 425 — Arcadia Biosciences, Inc. View Filing
edgar index 10-K/A — Arcadia Biosciences, Inc. View Filing
edgar index 8-K — Arcadia Biosciences, Inc. View Filing
edgar index 10-K — Arcadia Biosciences, Inc. View Filing
ten k section 10-K — business View Filing
ten k section 10-K — risk_factors View Filing
edgar index 8-K — Arcadia Biosciences, Inc. View Filing
edgar index S-4 — Arcadia Biosciences, Inc. View Filing
edgar index 4 — Arcadia Biosciences, Inc. View Filing
edgar index 4 — Arcadia Biosciences, Inc. View Filing
form 4 Form 4 — Schaefer Thomas J. View Filing
form 4 Form 4 — Kawakami Mark View Filing
edgar index SCHEDULE 13G/A — Arcadia Biosciences, Inc. View Filing
edgar index 8-K — Arcadia Biosciences, Inc. View Filing
edgar index 425 — Arcadia Biosciences, Inc. View Filing
edgar index 8-K — Arcadia Biosciences, Inc. View Filing
edgar index 425 — Arcadia Biosciences, Inc. View Filing
edgar index S-8 — Arcadia Biosciences, Inc. View Filing
edgar index 8-K — Arcadia Biosciences, Inc. View Filing
edgar index 10-Q — Arcadia Biosciences, Inc. View Filing
edgar index 8-K/A — Arcadia Biosciences, Inc. View Filing
edgar index 4 — Arcadia Biosciences, Inc. View Filing
edgar index 4 — Arcadia Biosciences, Inc. View Filing